Enovis Corp Asset Impairment Charges
Enovis Corp (ENOV) reported Asset Impairment Charges of $0 for the 6-month period ending 2025-07-04, per its 10-Q filed 2025-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2026-02-26
- Enovis Corp asset impairment charges for the quarter ending 2024-09-27 was $0.00.
- Enovis Corp asset impairment charges for the quarter ending 2024-06-28 was $155.00K.
- Enovis Corp asset impairment charges for the quarter ending 2024-03-29 was $5.40M.
- Enovis Corp asset impairment charges for the quarter ending 2023-09-29 was $0.00.
- Enovis Corp asset impairment charges for fiscal 2020 was $1.60M.
- Enovis Corp asset impairment charges for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Enovis Corp asset impairment charges for fiscal 2018 was $7.09M, a 96.14% decline from fiscal 2017.
- Enovis Corp asset impairment charges for fiscal 2017 was $183.75M, a 2921.23% increase from fiscal 2016.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month | Asset Impairment Charges 12 month as first filed |
|---|---|---|---|---|---|
| 2025-07-04 | $0.00 10-Q · filed 2025-08-07 | ||||
| 2024-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $155.00K derived: sum of 2 quarters · filed 2025-08-07 | $5.55M 10-Q · filed 2024-11-06 | ||
| 2024-06-28 | $155.00K derived: 10-Q 6 month − 10-K 3 month · filed 2025-08-07 | $5.55M 10-Q · filed 2025-08-07 | |||
| 2024-03-29 | $5.40M 10-K · filed 2026-02-26 | ||||
| 2023-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | |||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | ||||
| 2020-12-31 | $1.60M 10-K · filed 2023-03-01 | $0.00 10-K · filed 2021-02-18 | |||
| 2019-12-31 | -$700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | -$100.00K derived: sum of 2 quarters · filed 2021-02-18 | -$133.00K derived: sum of 3 quarters · filed 2021-02-18 | $0.00 10-K · filed 2021-02-18 | |
| 2019-09-27 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $567.00K derived: sum of 2 quarters · filed 2019-10-31 | $700.00K 10-Q · filed 2019-10-31 | ||
| 2019-06-28 | -$33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $100.00K 10-Q · filed 2019-08-06 | |||
| 2019-03-29 | $133.00K 10-Q · filed 2019-05-08 | ||||
| 2018-12-31 | $7.09M 10-K · filed 2021-02-18 | ||||
| 2017-12-31 | $183.75M 10-K · filed 2020-02-24 | ||||
| 2016-12-31 | $6.08M 10-K · filed 2019-02-21 | ||||
| 2015-12-31 | $12.51M 10-K · filed 2018-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |